Electronic signatures have become a practical, FDA-recognized way for pharmaceutical companies to approve documents, batch records, change controls and supplier agreements without printing, scanning and chasing ink signatures. Under the FDA’s 21 CFR Part 11 rule, electronic records and electronic signatures are accepted as trustworthy equivalents of paper records and handwritten signatures — provided the system and workflow meet defined controls. This article explains what that means in practice and outlines three types of solutions pharmaceutical distributors, manufacturers and quality teams use to reduce approval time while staying compliant.
What does FDA-recognized mean for electronic signatures?
The FDA does not issue “approvals” for specific electronic signature software the way it approves a drug. Instead, 21 CFR Part 11 sets out the conditions under which the agency will consider electronic records and electronic signatures to be trustworthy, reliable and equivalent to paper records. Any software you use must help you meet those conditions — which is why buyers should evaluate tools against Part 11’s controls rather than relying on marketing claims.
At a minimum, a compliant electronic signature must capture and display:
- The printed name of the signer.
- The date and time the signature was executed.
- The meaning of the signature — for example, review, approval or responsibility.
- A unique user identification code, and a signature that belongs only to that individual.
For signatures not based on biometrics, Part 11 requires at least two distinct identification components, such as a user ID combined with a password, and a documented process for ensuring each signature is used only by its genuine owner. A robust audit trail that records who signed, when, and what content was signed is central to staying inspection-ready.
Three types of electronic signature solutions for pharma
Most organizations combine one or more of the following approaches. Each saves meaningful time by removing the back-and-forth of paper approval cycles.
1. Enterprise e-signature platforms with a 21 CFR Part 11 configuration
General-purpose e-signature platforms such as DocuSign, Adobe Acrobat Sign and signNow are widely used in regulated industries because they offer settings designed for Part 11 compliance. These platforms typically provide:
- Signature manifestations that show the signer’s printed name, date, time and signing reason.
- User authentication through unique credentials and multi-factor options.
- Complete audit trails of every viewing, signing and record change.
- Validation documentation and controlled account configuration for regulated use.
For a distributor, these tools speed up supplier agreements, quality agreements, sales contracts and internal approvals. A signature that once took days across departments can be completed within hours because everyone signs from any device, with every transaction timestamped automatically.
2. Signatures built into quality management and electronic batch record systems
Pharmaceutical companies use electronic quality management systems (QMS), laboratory information management systems (LIMS) and electronic batch records (EBR) that include native electronic signature workflows. Because these systems already manage validated records, the signature is tied directly to the specific record, revision and approval step — the level of linkage Part 11 expects.
This is where the largest time savings usually come from. Approvals for change controls, deviations, CAPAs (corrective and preventive actions), and batch release can be routed automatically to the right reviewers in the correct sequence, with email reminders and an audit trail generated as the document moves forward.
3. Digital signature and document management for regulatory submissions
For submissions and documents exchanged with the FDA and other regulators, organizations increasingly use digital signatures that rely on cryptographic certificates issued by trusted Certificate Authorities. These provide the strongest form of identity verification and are often used for electronic submissions.
The value here is twofold: identity is verified cryptographically rather than by a typed name and password, and the signed document is tamper-evident, so a recipient can confirm it has not been altered. This matters when exchanging controlled documents with partners, contractors and regulators across borders.
What you need in place before going paperless
Buying software is only part of the work. To rely on electronic signatures, your organization should have:
- A signed policy declaring that electronic signatures are the legal equivalent of handwritten signatures and are binding.
- Validated systems that meet your documented quality requirements and, where applicable, good practice expectations.
- Trained signers who understand when their signature is being requested and what it authorizes.
- User controls so each person has unique credentials and no one can sign on behalf of another without proper authorization.
- Documented procedures covering signature use, password management and how records are retained.
An audit trail is not optional. Inspectors expect to be able to reconstruct who approved what, when, and in the correct sequence. Choose a solution that records actions automatically and makes the trail tamper-resistant and easy to retrieve.
How to evaluate a solution for your business
Before selecting a platform, compare vendors on the factors that affect both compliance and actual time saved:
- Part 11 features: Does it capture printed name, date, time and signing reason, and enforce unique user IDs?
- Audit trail: Can you generate a complete, exportable history of each document?
- Validation support: Does the vendor provide documentation to support your system validation?
- Authentication: Does it support at least two identification components and configurable policies?
- Workflow automation: Can approvals be routed and sequenced automatically, with reminders?
- Integration: Does it connect with your ERP, QMS or e-commerce systems so records flow without re-entry?
Running a pilot on a real, low-risk workflow — such as internal SOP approvals or sales contracts — is the most reliable way to measure the time your team will actually save before scaling across the organization.
Key takeaways
- FDA-recognized electronic signatures, governed by 21 CFR Part 11, are a legitimate alternative to paper signatures when controls are met.
- The biggest time savings usually come from routing approvals automatically in quality systems, not from simply stamping PDFs.
- Evaluate vendors on Part 11 features, audit trails, validation support and workflow automation, not on marketing language.
- Put the required policy, validation, training and user controls in place before going paperless.
Frequently asked questions
Does the FDA approve electronic signature software?
No. The FDA recognizes electronic signatures under 21 CFR Part 11 when systems and workflows satisfy the rule’s controls. There is no product “approval” for e-signature software.
Are electronic signatures legally binding in pharmaceutical business?
Yes, where they meet applicable regulatory requirements such as 21 CFR Part 11, and when the organization has a policy confirming electronic signatures are the equivalent of handwritten signatures.
What does an audit trail need to show?
It should record who signed, when, the content signed, and the meaning of the signature, in a secure, tamper-resistant and retrievable form.
This article is for general business information. Validation, compliance and record-keeping requirements vary by region, product and operation; consult qualified regulatory professionals and review the applicable regulations for your specific circumstances.